Leishmania is not prone to develop resistance to tamoxifen.
about
Selenophene and thiophene-core estrogen receptor ligands that inhibit motility and development of parasitic stages of Haemonchus contortus.Selective inhibition of RNA polymerase I transcription as a potential approach to treat African trypanosomiasis.Efficacy of tamoxifen and miltefosine combined therapy for cutaneous leishmaniasis in the murine model of infection with Leishmania amazonensis.Tamoxifen inhibits the biosynthesis of inositolphosphorylceramide in Leishmania
P2860
Leishmania is not prone to develop resistance to tamoxifen.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Leishmania is not prone to develop resistance to tamoxifen.
@ast
Leishmania is not prone to develop resistance to tamoxifen.
@en
type
label
Leishmania is not prone to develop resistance to tamoxifen.
@ast
Leishmania is not prone to develop resistance to tamoxifen.
@en
prefLabel
Leishmania is not prone to develop resistance to tamoxifen.
@ast
Leishmania is not prone to develop resistance to tamoxifen.
@en
P2093
P2860
P1476
Leishmania is not prone to develop resistance to tamoxifen.
@en
P2093
Adriano C Coelho
Cristiana T Trinconi
Jenicer K U Yokoyama-Yasunaka
Luisa Senra
Silvia R B Uliana
P2860
P356
10.1016/J.IJPDDR.2015.05.006
P577
2015-06-17T00:00:00Z